MicroRNA-365, down-regulated in colon cancer, inhibits cell Cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2

Carcinogenesis

Volumn 33, Issue 1, 2012, Pages 220-225

  Nie, Jing ^a   Liu, Lin ^a   Zheng, Wei ^a   Chen, Lin ^a   Wu, Xin ^a   Xu, Yingxin ^a   Du, Xiaohui ^a   Han, Weidong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; FLUOROURACIL; MICRORNA; MICRORNA 365; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENICITY; CELL CYCLE PROGRESSION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS;

EID: 84855387995     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr245     Document Type: Article

References (28)

1. Weitz,J. et al. (2005) Colorectal cancer. Lancet, 365, 153-165.
2. Jemal,A. et al. (2007) Cancer statistics. CA Cancer J. Clin., 57, 43-66.
3. Saif,M.W. et al. (2010) Biology of colorectal cancer. Cancer J., 16, 196-201.
4. Bartel,D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
5. Brennecke,J. et al. (2003) bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell, 113, 25-36.
6. Poy,M.N. et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature, 432, 226-230.
7. Thai,T.H. et al. (2007) Regulation of the germinal center response by microRNA-155. Science, 316, 604-608.
8. Bushati,N. et al. (2007) microRNA functions. Annu. Rev. Cell Dev. Biol., 23, 175-205.
9. Slaby,O. et al. (2009) MicroRNAs in colorectal cancer: translateon of molecular biology into clinical application. Mol. Cancer, 8, 102.
10. Hou,J. et al. (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell, 19, 232-243.
11. Guo,L. et al. (2009) Differential expression profiles of microRNAs in NIH3T3 cells in response to UVB irradiation. Photochem. Photobiol., 85, 765-773.
12. Maes,O.C. et al. (2009) Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. J. Cell. Physiol., 221, 109-119.
13. Yan,L. et al. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage lymph node metastasis and patient poor prognosis. RNA, 14, 2348-2360.
14. Ohlsson Teague,E.M. et al. (2009) MicroRNA-regulated pathways associated with endometriosis. Mol. Endocrinol., 23, 265-275.
15. Wang,X. et al. (2010) Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells. Mol. Cell. Biochem., 345, 283-290.
16. Xie,P. et al. (2008) Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes. Cell. Signal., 20, 1671-1678.
17. Livak,K.J. et al. (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2-DDCt method. Methods, 25, 402-408.
18. Nie,J. et al. (2010) Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2. J. Biol. Chem., 285, 22818-22830.
19. Liu,L. et al. (2010) microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem. Biophys. Res. Commun., 400, 236-240.
20. Bhatavdekar,J.M. et al. (1997) Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma. Dis. Colon Rectum, 40, 785-790.
21. Holland,T.A. et al. (2001) Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21(WAF1/CIP1) expression and correlates with patient survival. Int. J. Cancer, 95, 302-306.
22. Kim,J.K. et al. (2009) Nuclear cyclin D1: an oncogenic driver in human cancer. J. Cell. Physiol., 220, 292-296.
23. Michael,M.Z. et al. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res., 1, 882-891.
24. Akao,Y. et al. (2006) let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol. Pharm. Bull., 29, 903-906.
25. Schetter,A.J. et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-436.
26. Motoyama,K. et al. (2009) Over- and under-expressed microRNAs in human colorectal cancer. Int. J. Oncol., 34, 1069-1075.
27. Longley,D.B. et al. (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer, 3, 330-338.
28. Lea,M.A. (2010) Recently identified and potential targets for colon cancer treatment. Future Oncol., 6, 993-1002.